Stereotaxis Inc. (STXS)
2.08
0.00 (0.00%)
At close: Jan 14, 2025, 3:59 PM
2.07
-0.24%
After-hours Jan 14, 2025, 08:00 PM EST
undefined% (undefined)
| Bid | 2.02 |
| Market Cap | 175.81M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -7.69 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 3.31 |
| Volume | 129,103 |
| Avg. Volume (20D) | 373,067 |
| Open | 2.14 |
| Previous Close | 2.08 |
| Day's Range | 2.05 - 2.16 |
| 52-Week Range | 1.66 - 3.29 |
| Beta | undefined |
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Aug 12, 2004
Employees 122
Stock Exchange AMEX
Ticker Symbol STXS
Website https://www.stereotaxis.com
Analyst Forecast
According to 2 analyst ratings, the average rating for STXS stock is "Strong Buy." The 12-month stock price forecast is $4.5, which is an increase of 116.87% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Stereotaxis Inc. is scheduled to release its earnings on Mar 3, 2025,
during market hours.
Analysts project revenue of $8.07M, reflecting a 76.78% YoY growth and earnings per share of -0.06, making a -14.29% decrease YoY.
Analysts project revenue of $8.07M, reflecting a 76.78% YoY growth and earnings per share of -0.06, making a -14.29% decrease YoY.
5 months ago ·
Source
-3.74%
Stereotaxis shares are trading higher after the co...
Unlock content with
Pro Subscription
